Form 4: RTW Investments LP Acquires 50,000 Shares of Orchestra BioMed Holdings, Inc.

RTW Investments LP reports the acquisition of 50,000 shares of Orchestra BioMed Holdings, Inc. at $2.53 per share, increasing their indirect holdings.

Summary

• On April 29, 2025, RTW Investments, LP acquired 50,000 shares of Orchestra BioMed Holdings, Inc. common stock.
• The purchase price was $2.53 per share.
• Following the transaction, RTW Investments, LP indirectly holds 8,256,163 shares of Orchestra BioMed Holdings, Inc.
• Roderick Wong, Managing Partner and Chief Investment Officer of RTW Investments, LP, signed the report on behalf of RTW Investments, LP and in his individual capacity.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it is a standard SEC filing reporting a transaction. The acquisition itself could be seen as mildly positive, but the filing is simply a factual disclosure.

Positives

• The acquisition of additional shares by a significant shareholder like RTW Investments, LP could be interpreted positively by the market.

Management Comments

• The reporting persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders or significant shareholders of a publicly traded company buy or sell shares. This filing indicates a change in ownership by a major shareholder of Orchestra BioMed Holdings, Inc.

Key Dates

Keywords

Orchestra BioMed Holdings, RTW Investments, share acquisition, Form 4, beneficial ownership, OBIO, Roderick Wong